SANTEN PHARMACEUTICAL CO's ticker is and the CUSIP is 006776606. A total of 1 filers reported holding SANTEN PHARMACEUTICAL CO in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,163,228,000 | -20.3% | 71,700 | 0.0% | 0.32% | -28.5% |
| Q3 2020 | $1,460,090,000 | +18.4% | 71,700 | +6.9% | 0.45% | +18.9% |
| Q2 2020 | $1,233,344,000 | +6.8% | 67,100 | 0.0% | 0.38% | -14.8% |
| Q1 2020 | $1,154,850,000 | +71.4% | 67,100 | +91.2% | 0.45% | +123.5% |
| Q4 2019 | $673,739,000 | +10.5% | 35,100 | 0.0% | 0.20% | 0.0% |
| Q3 2019 | $609,926,000 | +4.9% | 35,100 | 0.0% | 0.20% | +19.0% |
| Q2 2019 | $581,525,000 | +11.2% | 35,100 | 0.0% | 0.17% | +9.1% |
| Q1 2019 | $522,925,000 | +16.7% | 35,100 | +13.2% | 0.15% | +6.2% |
| Q4 2018 | $448,125,000 | -8.8% | 31,000 | 0.0% | 0.14% | +5.8% |
| Q3 2018 | $491,535,000 | -9.0% | 31,000 | 0.0% | 0.14% | -12.7% |
| Q2 2018 | $540,432,000 | +8.1% | 31,000 | 0.0% | 0.16% | +8.3% |
| Q1 2018 | $499,906,000 | +2.6% | 31,000 | 0.0% | 0.14% | +9.0% |
| Q4 2017 | $487,359,000 | -0.2% | 31,000 | 0.0% | 0.13% | +5.6% |
| Q3 2017 | $488,278,000 | +16.1% | 31,000 | 0.0% | 0.13% | +48.2% |
| Q2 2017 | $420,470,000 | -6.2% | 31,000 | 0.0% | 0.08% | 0.0% |
| Q1 2017 | $448,461,000 | +916.0% | 31,000 | +761.1% | 0.08% | +962.5% |
| Q4 2016 | $44,138,000 | – | 3,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PARADIGM ASSET MANAGEMENT CO LLC | 31,000 | $487,359,000 | 0.13% |